Literature DB >> 12233202

Establishing the real cost of depression.

David V Sheehan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12233202

Source DB:  PubMed          Journal:  Manag Care        ISSN: 1062-3388


× No keyword cloud information.
  9 in total

1.  [Health-related quality of life (SF-36) in chronic low back pain and comorbid depression].

Authors:  C Ahrens; M Schiltenwolf; H Wang
Journal:  Schmerz       Date:  2010-06       Impact factor: 1.107

2.  The importance of somatic symptoms in depression in primary care.

Authors:  André Tylee; Paul Gandhi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 3.  Escitalopram: a pharmacoeconomic review of its use in depression.

Authors:  Katherine F Croom; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Influence of comorbidity with depression on interdisciplinary therapy: outcomes in patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Marcus Schiltenwolf
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

5.  Influence of depression symptoms on serum tumor necrosis factor-α of patients with chronic low back pain.

Authors:  Haili Wang; Carsten Ahrens; Winfried Rief; Simone Gantz; Marcus Schiltenwolf; Wiltrud Richter
Journal:  Arthritis Res Ther       Date:  2010-10-11       Impact factor: 5.156

6.  Sex differences in recent first-onset depression in an epidemiological sample of adolescents.

Authors:  J Breslau; S E Gilman; B D Stein; T Ruder; T Gmelin; E Miller
Journal:  Transl Psychiatry       Date:  2017-05-30       Impact factor: 6.222

7.  The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression.

Authors:  M Morais; P Patrício; A Mateus-Pinheiro; N D Alves; A R Machado-Santos; J S Correia; J Pereira; L Pinto; N Sousa; J M Bessa
Journal:  Transl Psychiatry       Date:  2017-06-06       Impact factor: 6.222

8.  Effectiveness and cost-effectiveness of transmural collaborative care with consultation letter (TCCCL) and duloxetine for major depressive disorder (MDD) and (sub)chronic pain in collaboration with primary care: design of a randomized placebo-controlled multi-Centre trial: TCC:PAINDIP.

Authors:  Eric W de Heer; Jack Dekker; Jonna F van Eck van der Sluijs; Aartjan Tf Beekman; Harm Wj van Marwijk; Tjalling J Holwerda; Pierre M Bet; Joost Roth; Leona Hakkaart-Van Roijen; Lianne Ringoir; Fiona Kat; Christina M van der Feltz-Cornelis
Journal:  BMC Psychiatry       Date:  2013-05-24       Impact factor: 3.630

9.  Remission from Depression among Adults with Arthritis: A 12-Year Followup of a Population-Based Study.

Authors:  Esme Fuller-Thomson; Marla Battiston; Tahany M Gadalla; Yael Shaked; Ferrah Raza
Journal:  Depress Res Treat       Date:  2014-01-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.